Glutathione S-transferases as molecular markers of tumour progression and prognosis in renal cell carcinoma

Histopathology

Volumn 58, Issue 2, 2011, Pages 180-190

  Searchfield, Lydia ^a,b   Price, Sally A ^c   Betton, Graham ^c   Jasani, Bharat ^b   Riccardi, Daniela ^a,b   Griffiths, David F R ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c ASTRAZENECA   (United Kingdom)

Author keywords

3,3' diaminobenzidine; Glutathione S transferases; Horseradish peroxidase; Immunohistochemistry; Prognostic indicators; Renal cell carcinoma; Tissue microarray; Western blotting

Indexed keywords

GLUTATHIONE TRANSFERASE ALPHA;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR GROWTH; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, RENAL CELL; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

ARMORACIA RUSTICANA;

EID: 79951671837     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03733.x     Document Type: Article

References (37)

1. Chuang S, Chu P, Sugimura J et al. Overexpression of glutathione S-transferase α in clear cell renal carcinoma. Am. J. Clin. Pathol. 2005; 123; 421-429.
2. Llungberg B. Prognostic markers in renal cell carcinoma. Curr. Opin. Urol. 2007; 17; 303-308.
3. Park WH, Eisen T. Prognostic factors in renal cell carcinoma. BJU Int. 2007; 99; 1277-1281.
4. Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR. Renal cell cancer stage migration. Cancer 2008; 113; 78-83.
5. Lusini L, Tripodi SA, Rossi R et al. Altered glutathione anti-oxidant metabolism during tumor progression in human renal-cell carcinoma. Int. J. Cancer 2001; 91; 55-59.
6. Pljesa-Ercegovac M, Mimic-Oka J, Dragicevic D et al. Altered antioxidant capacity in renal cell carcinoma: role of glutathione associated enzymes. Urol. Oncol. 2008; 26; 175-181.
7. Zhu H, Zhang L, Amin AR, Li Y. Coordinated upregulation of a series of endogenous antioxidants and phase 2 enzymes as a novel strategy for protecting renal tubular cells from oxidative and electrophilic stress. Exp. Biol. Med. 2008; 233; 753-765.
8. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases-the first enzymatic step in maercapturic acid formation. J. Biol. Chem. 1974; 249; 7130-7139.
9. Dekant W. Bioactivation of nephrotoxins and renal carcinogens by glutathione S-conjugate formation. Toxicol. Lett. 1993; 67; 151-160.
10. Karami S, Boffetta P, Rothman N et al. Renal cell carcinoma, occupational pesticide exposure and modification by glutathione S-transferase polymorphisms. Carcinogenesis 2008; 29; 1567-1571.
11. Savic-Radojevic A, Mimic-Oka J, Pljesa-Ercegovac M et al. Glutathione S-transferase-P1 expression correlates with increased antioxidant capacity in transitional cell carcinoma of the urinary bladder. Eur. Urol. 2007; 52; 470-477.
12. Asakura T, Imai A, Ohkubo-Uraoka N et al. Relationship between expression of drug-resistance factors and drug sensitivity in normal human renal proximal tubular epithelial cells in comparison with renal cell carcinoma. Oncol. Rep. 2005; 14; 601-607.
13. Dulik DM, Fenselau C, Hilton J. Characterization of melphalan-glutathione adducts whose formation is catalysed by glutathione transferases. Biochem. Pharmacol. 1986; 35; 3405-3409.
14. Peters WHM, Roelofs HMJ. Biochemical characterization of resistance to mitoxantrone and adriamycin in Caco-2 human colon adenocarcinoma cells: a possible role for glutathione S-transferases. Cancer Res. 1992; 52; 1886-1890.
15. Lui L, Qian J, Singh H, Meiers I, Zhou X, Bostwick DG. Immunohistological analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma. Arch. Pathol. Lab. Med. 2007; 131; 1290-1297.
16. Howie AF, Forrester LM, Glancy MJ et al. Glutathione S-transferase and glutathione peroxidase expression in normal and tumour human tissue. Carcinogenesis 1990; 11; 451-458.
17. Klone A, Weidner U, HuBnatter R et al. Decreased expression of the glutathione S-transferase alpha and pi genes in human renal cell carcinoma. Carcinogenesis 1990; 11; 2179-2183.
18. Sweeney C, Farrow DC, Schwartz SM, Eaton DL, Checkoway H, Vaughan TL. Glutathione S-tranferase M1, T1 and P1 polymorphisms as risk factors for renal cell carcinoma: a case control study. Cancer Epidemol. Biomark. Prev. 2000; 9; 449-454.
19. Simic T, Mimic-Oka J, Ille K, Savic-Radojevic A, Reljic Z. Isoenzyme profile of glutathione S-transferases in human kidney. Urol. Res. 2001; 29; 38-44.
20. Simić T, Mimić-Oka J, Ille K, Dragicević D, Savić-Radojević A. Glutathione S-transferase isoenzyme profile in non-tumor and tumor human kidney tissue. World J. Urol. 2003; 20; 385-391.
21. van den Berg E, Störkel S. Kidney: clear cell renal cell carcinoma. Atlas Genet. Cytogenet. Oncol. Haematol. 2004; URL:
22. Sárváry E, Blázovics A, Varga M et al. Diagnostic value of glutathione-S-transferase. Orv. Hetil. 1998; 139; 1531-1537.
23. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 1995; 30; 445-600.
24. Wang W, Lui G, Zheng J. Human renal UOK130 tumour cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-π isozyme. Eur. J. Pharmacol. 2007; 568; 61-67.
25. Thomas DH, Verghase A, Kynaston HG, Driffiths DFR. Analysis of the prognostic implifications of different tumour margin types in renal cell carcinoma. Histopathology 2003; 43; 374-380.
26. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphological parameters in renal cell carcinoma. Am. J. Surg. Pathol. 1982; 6; 655-663.
27. Kovacs G, Akhtar M, Beckwith BJ et al. The Heidelberg classification of renal cell carcinomas. J. Pathol. 1997; 183; 131-133.
28. Griffiths DFR, Verghese A, Golash A et al. Contribution of grade, vascular invasion and age to outcome in clinically localised renal cell carcinoma. BJU Int. 2002; 90; 26-31.
29. Campbell L, Gumbleton M, Griffiths DFR. Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma. Br. J. Cancer 2003; 89; 1909-1913.
30. Takahashi M, Yang XJ, Sugimura J et al. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogene 2003; 22; 6810-6818.
31. Allory Y, Bazille C, Vieillefond A et al. Profiling and classification tree applied to renal epithelial tumours. Histopathology 2008; 52; 158-166.
32. Martignoni G, Pea M, Brunelli M et al. CD10 is expressed in a subset of chromophobe renal cell carcinomas. Mod. Pathol. 2004; 17; 1455-1463.
33. Toyokuni S, Okamoto K, Yodoi J, Hiai H. Persistent oxidative stress in cancer. FEBS Lett. 1995; 358; 1-3.
34. Shea TC, Kelley SL, Henner WD. Identification of an anionic form of glutathione transferase present in many human tumors and human tumor cell lines. Cancer Res. 1988; 48; 527-533.
35. Harrison DJ, Kharbanda R, Bishop D, McLelland LI, Hayes JD. Glutathione S-transferase isoenzymes in human renal carcinoma demonstrated by immunohistochemistry. Carcinogenesis 1989; 10; 1257-1260.
36. Adler V, Yin Z, Fuchs SY et al. Regulation of JNK signaling by GSTp. EMBO J. 1999; 18; 1321-1334.
37. Townsend DM, Tew KD. The role of glutathione S-tranferase in anti-cancer drug resistance. Oncogene 2003; 22; 7369-7375.